Response to Comments: Magnesium

This document records the administrative timeline for the Magnesium LCD L39400: the public comment period ran 2022-09-01 to 2022-10-15, the notice period begins 2022-12-08, and the LCD becomes effective 2023-01-22. No provider comments were received during the comment period; no clinical coverage criteria or changes are specified in this response.

"LCD L39400 (Magnesium) comment period was 2022-09-01 to 2022-10-15; notice period begins 2022-12-08 and the LCD becomes effective 2023-01-22; no comments were received from the provider community."

Sign up to see full coverage criteria, indications, and limitations.